Verista acquires Hawkins Point for Business and Technology Prowess throughout the drug development life cycle News Highlights: Verista acquires Hawkins Point for Business and Technology Prowess throughout the drug development life cycle “Hawkins Point’s expertise in R&D and commercialization is a natural extension of Verista’s capabilities.” tweet this Recommended “The Hawkins Point team shares Verista’s mission to trust and ultimately improve patients’ quality of life,” said Heather Morris Kyer, Hawkins Point co-founder, who will join Verista’s leadership team. “We are thrilled to be an important part of Verista as we collectively gain greater scale and capabilities to serve our customers.”